Allergy and Immunology · Oak Park, MI
NPI
1477849610
Since 2011
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
24601 Coolidge Hwy
Oak Park, MI, 48237
Phone (248) 546-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
3,011 services
Medicare patients, 2024
110
Average age 70
Drug cost, 2024
$2.7M
2,859 prescriptions
Company payments, 2025
$58K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathleen Dass was code 95004 (test - miscellaneous), 1,309 times for 26 patients. In total Kathleen Dass billed 3,011 services in 19 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,309 | 26 | $3.02 | $3,947 |
| 96372 Injection Administration | Office | 496 | 70 | $10.02 | $4,970 |
| 95117 Treatment - Miscellaneous | Office | 359 | 24 | $8.49 | $3,049 |
| 99214 Office E&M - Established | Office | 254 | 100 | $93.67 | $24K |
| 94060 Pulmonary Function Testing | Office | 219 | 84 | $27.89 | $6,107 |
| 95165 Treatment - Miscellaneous | Office | 186 | 20 | $11.23 | $2,089 |
| 36415 Venipuncture Blood Collection | Office | 40 | 34 | $8.65 | $346 |
| 99213 Office E&M - Established | Office | 29 | 19 | $52.24 | $1,515 |
| 99204 Office E&M - New | Office | 27 | 27 | $124.05 | $3,349 |
By year: 2022 $49K for 3,061 services; 2023 $54K for 3,544 services; 2024 $50K for 3,011 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 40 | 34 | $8.65 | $346 |
Medicare prescription drug claims, 2024
In 2024, the drug Kathleen Dass prescribed most often to Medicare patients was Montelukast Sodium, with 396 prescriptions and refills. In total Kathleen Dass wrote 2,859 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 396 | 988 | 158 | $6,511 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 352 | 420 | 82 | $262K |
| Xolair Omalizumab | 312 | 312 | 35 | $864K |
| Fluticasone Propionate Generic | 203 | 370 | 79 | $4,061 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 171 | 187 | 63 | $5,559 |
| Famotidine Generic | 143 | 371 | 70 | $2,271 |
| Dupixent Syringe Dupilumab | 138 | 143 | 20 | $542K |
| Azelastine Hcl Generic | 113 | 187 | 42 | $3,905 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 104 | 107 | 26 | $65K |
| Ipratropium Bromide Generic | 89 | 121 | 29 | $2,507 |
| Nucala Mepolizumab | 74 | 83 | Under 11 | $315K |
| Arnuity Ellipta Fluticasone Furoate | 56 | 64 | 15 | $16K |
| Dupixent Pen Dupilumab | 50 | 50 | Under 11 | $188K |
| Prednisone Generic | 41 | 41 | 26 | $63.79 |
| Methylprednisolone Generic | 35 | 35 | 31 | $233 |
Brand drugs: 1,437 claims; generic drugs: 1,422 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathleen Dass $58K ($58K in general payments such as food, travel and fees) from 17 companies. The largest payer was Genzyme Corporation with $12K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 16 | $12K |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $11K |
| AstraZeneca Pharmaceuticals LP AZN | 47 | $11K |
| GlaxoSmithKline, LLC. GSK | 30 | $9,967 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $6,991 |
| Genentech USA, Inc. ROG.SW | 11 | $5,450 |
| Amgen Inc. AMGN | 20 | $320 |
| CSL Behring CSL.AX | 12 | $244 |
| Pfizer Inc. PFE | 2 | $124 |
| Organon LLC OGN | 5 | $73.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.